3 Top Pharma Stocks to Buy Now
Stocks of large pharmaceutical companies haven't had a great year in 2020. When investors weren't trying to figure out which businesses would be winners from the pandemic, they were searching out the best growth stories in the technology and consumer sectors.
Investor attention might shift if signs emerge that a vaccine-driven economic recovery is weaker than expected. When the market starts anticipating slow or negative growth, steady and predictable businesses that pay dividends tend to become more valuable.
Pharma stocks in general may be out of favor now, but below are three that I think are particularly timely buys for patient contrarian investors. All three have excellent growth prospects and pay healthy dividends.
Source Fool.com
